change in statistical and bioanalytical site a form IEC appr [Regulatives / Guidelines]

posted by vivekanand – India, 2013-05-25 08:16 (4785 d 13:30 ago) – Posting: # 10652
Views: 2,629

Dear All

In general BA/BE protocol specify the details of Facility address where the study shall be conducted like Clinical site, Statistical sit, Analytical site, Radiological site, Lab Diagnostic site, For which protocol shall be approved from IEC and DCG(I) for T-license and BE-NOc (if required),

If the clinical part of the study couducted in the site mentioned in IEC approved protocol,later this site is shifted to new facility from the existing site (where new facility is approved by DCG(I) and other regulatory bodies if required). Rest of the study part that is Bioanalytical and Statistical part of the BA/BE study conducted in new site. What is the regulatory stand for this?

what are the approvals required.

Regards
BalaVivekanand

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
307 visitors (0 registered, 307 guests [including 19 identified bots]).
Forum time: 21:47 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5